welcome to DuchenneXchange- a positively charged Duchenne muscular dystrophy community.
- join today!
A Registered Cohort Study on Duchenne Muscular Dystrophy
study id #: NCT04012671
condition: Duchenne Muscular Dystrophy
Dystrophinopathy is a term of X-linked recessive genetic disease, including Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and the X-linked dilated cardiomyopathy. The aim of this study is to determine the clinical spectrum and natural progression of dystrophinopathy in a prospective multicenter natural history study, to assess the clinical, genetic of patients with dystrophinopathy to optimize clinical management.
mechanism of action: No pharmaceutical intervention
last updated: February 25, 2020
start date: July 1, 2019
estimated completion: December 31, 2039
phase of development: N/A
size / enrollment: 2000
- Age at death [ Time Frame: 20 years ]
The time when patient die
• Eligible Sexes: all
• Beyond 2 years old
• Diagnosis with Duchenne Muscular Dystrophy, and female carriers, genotypically confirmed
• Diagnosis should be supported by muscle biopsy, if no genetic confirmation.
• Presence of other clinically significant illness
other Duchenne content
Duchenne Muscular Dystrophy Key PointsDuchenne muscular dystrophy is caused by...
Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular DystrophyThe aim of this multicentre, prospective...
What is the Level of Dystrophin Expression Required for Effective Therapy of Duchenne Muscular Dystrophy?Duchenne muscular dystrophy (DMD) is a f...
Avidity Biosciences Receives Investment from CureDuchenneAvidity Biosciences, a privately held bi...
Study of DS-5141b in Patients With Duchenne Muscular DystrophyThis is a phase I/II study to evaluate t...
Dennis Matthews, MDDr. Dennis Matthews, MD, is a neuromuscu...
Duchenne Pulmonary Awareness: Assisted coughhttps://www.youtube.com/watch?v=qgTlNwXy...